PRESS RELEASE published on 06/18/2026 at 07:30, 3 months 20 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
BRIEF published on 05/28/2026 at 19:11, 4 months 10 days ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
BRIEF published on 05/28/2026 at 19:11, 4 months 10 days ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
PRESS RELEASE published on 05/28/2026 at 19:06, 4 months 10 days ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
PRESS RELEASE published on 05/27/2026 at 07:30, 4 months 12 days ago Inside Information / Other news releases ABIONYX Pharma launches a fully secured capital increase with preferential subscription rights and structured debt financing for up to EUR 33M. Finnja Capital commits EUR 10M in a non-dilutive loan Capital Increase Preferential Subscription Rights ABIONYX Pharma Fenja Capital Structured Debt Financing
BRIEF published on 04/08/2026 at 23:59, 5 months 29 days ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 5 months 29 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 6 months 21 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 6 months 21 days ago Inside Information / Other news releases ABIONYX Pharma announces the availability of its Universal Registration Document for the year 2025, filed with the AMF and accessible on their website AMF Biopharmaceutical Universal Registration Document ABIONYX Pharma Sepsis
BRIEF published on 03/03/2026 at 19:40, 7 months 4 days ago ABIONYX: Information on voting rights and shares as of February 28, 2026 Euronext Paris Share Capital Voting Rights AMF ABIONYX
Published on 10/07/2026 at 23:30, 9 hours 14 minutes ago Algo Grande Copper Core Testing Shows Mineralized Skarn is Denser and More Chargeable Than Host Rocks; Ground Gravity Survey to Begin at Adelita
Published on 10/07/2026 at 22:05, 10 hours 39 minutes ago Loar Holdings Inc. Announces Date and Time for Third Quarter 2026 Earnings and Conference Call
Published on 10/07/2026 at 17:00, 15 hours 44 minutes ago BlackBerry Radar Expands Asset Intelligence Platform with Dynamic Pairing
Published on 10/07/2026 at 15:30, 17 hours 14 minutes ago Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 18 hours 14 minutes ago Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/08/2026 at 08:00, 44 minutes ago PATRIMOINE ET COMMERCE: Q3 2026 RESULTS +5.0% IN GROSS RENTAL INCOME AT €45.4M
Published on 10/08/2026 at 08:00, 44 minutes ago Custodian Property Income REIT plc: Disposal of Petrol Station at an 8% Premium to Valuation
Published on 10/08/2026 at 07:30, 1 hour 14 minutes ago AGRANA posts significantly improved first-half results
Published on 10/07/2026 at 18:19, 14 hours 24 minutes ago Outstanding shares and voting rights statement at 30 September 2026
Published on 10/07/2026 at 17:45, 14 hours 59 minutes ago Availability of the Pre-Q3 2026 Sales Communication
Published on 10/07/2026 at 15:54, 16 hours 49 minutes ago Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 08:15, 1 day ago EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS
